DARA BioSciences, Inc. (Nasdaq: DARA) announced that the Company signed a Medicare Part D Prescription Drug Program Reimbursement Agreement with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE